391 related articles for article (PubMed ID: 8862258)
21. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
22. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
23. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
24. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
25. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
[No Abstract] [Full Text] [Related]
26. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS
Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628
[TBL] [Abstract][Full Text] [Related]
27. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
28. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
30. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
Floch HA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
[TBL] [Abstract][Full Text] [Related]
31. [Advances in the chemotherapy of leprosy].
Grosset J
Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
[TBL] [Abstract][Full Text] [Related]
32. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
33. [2 cases of paucibacillary leprosy resistant to dapsone].
Janssens L
Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
[TBL] [Abstract][Full Text] [Related]
34. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
35. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
[TBL] [Abstract][Full Text] [Related]
36. Prevalence survey of secondary dapsone resistance in leprosy in Kancheepuram and Tiruvannamalai control units of Tamil Nadu.
Neelan PN; Noordeen SK; Balakrishnan S; Pandian PR
Lepr India; 1983 Apr; 55(2):222-30. PubMed ID: 6355650
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
Sreevatsa ; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
[TBL] [Abstract][Full Text] [Related]
38. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
[TBL] [Abstract][Full Text] [Related]
39. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
[TBL] [Abstract][Full Text] [Related]
40. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
